查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球基质血管分割市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按应用、按最终用户、按地区
市场调查报告书
商品编码
1398762

全球基质血管分割市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按应用、按最终用户、按地区

Stromal Vascular Fraction Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 183 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计 2024 年全球基质血管成分 (SVF) 市场规模约为 9,600 万美元，到 2031 年底可望达到约 1.31 亿美元。 新型自动化即时护理 (POC) 设备的开发、成本效益以及 SVF 疗法的日益普及推动了市场的发展。

包括 SVF 在内的干细胞疗法在医疗保健领域具有巨大潜力。 然而，SVF 疗法的实际实施在许多医疗机构面临知识、基础设施和物资方面的挑战。 为了克服这些障碍，公司和研究机构正在开发自动化 POC 设备，以简化 SVF 分离流程。 这些设备在消除运输需求、降低处理成本和最小化对组织的操作方面具有显着的优势。 降低成本、易用性和改善患者治疗效果是市场成长的关键驱动力。

SVF 市场成长的挑战包括监管合规问题和先进基础设施的需求。 过去，一些医疗器材製造商将其产品推向监管界限之外，影响了患者对脂肪干细胞治疗的认知和采用。 遵守法规对于确保病患安全至关重要。

由于无尘室设施、专业设备、技术能力和 cGMP 合规性等基础设施要求，SVF 的实施仅限于大型城市医院。 要获得这些程序的报销仍然很困难，从而降低了市场渗透率。

本报告调查了全球基质血管成分市场，并提供了市场概述，以及按产品、应用、最终用户、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章 2018-2031 年全球基质血管成分市场前景

  • 2018-2031 年全球基质血管分离市场前景（按产品、价值（百万美元））
  • 2018-2031 年全球基质血管分离市场前景（按应用、价值（百万美元））
  • 2018-2031 年全球基质血管分割市场前景（以最终用户划分）价值（百万美元）
  • 2018-2031 年全球基质血管分割市场前景（按地区、价值（百万美元））

第 4 章 2018-2031 年北美基质血管成分市场前景

第 5 章欧洲基质血管成分市场前景，2018-2031

第 6 章亚太基质血管分割市场展望，2018-2031

第 7 章拉丁美洲基质血管分割市场展望，2018-2031

第 8 章中东与非洲基质血管分离市场展望，2018-2031

第九章竞争态势

  • 按细分和使用情况划分的热图
  • 按製造商和应用程式划分的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Cytori Therapeutics Inc.
    • IntelliCell BioSciences Inc.
    • Cellular Biomedicines Group, Inc.
    • GE Healthcare (Biosafe Group SA)
    • Lifecell Corporation (Allergen PLC)
    • Tissue Genesis Inc.
    • InGeneron, Inc.
    • Human med AG
    • MEDICAN CO., LTD
    • Hairline International
    • Genesis Biosystems, Inc.
    • iXCells Biotechnologies USA, LLC
    • Kyocera Corporation
    • Medikan International Inc

第 10 章附录

简介目录

The global Stromal Vascular Fraction (SVF) market, with revenues of approximately US$ 96 million in 2024, is on track to achieve a valuation of around US$ 131 million by the end of 2031. The market's growth is being driven by the development of new automated Point-of-Care (POC) devices, cost-effectiveness, and the rising adoption of SVF therapies.

Driving Growth: Development of Automated POC Devices

Stem cell therapies, including SVF procedures, hold great promise in healthcare. However, the practical implementation of SVF therapies faces challenges in terms of knowledge, infrastructure, and supplies in many healthcare facilities. To overcome these obstacles, companies and research laboratories are developing automated POC devices to streamline SVF isolation processes. These devices eliminate the need for transport, reduce processing costs, and offer significant advantages in terms of minimal manipulation of tissue. Cost savings, ease of use, and improved patient outcomes are key drivers of market growth.

Challenges: Regulatory Compliance and Infrastructure

Challenges to SVF market growth include regulatory compliance issues and the need for advanced infrastructure. In the past, some medical device companies pushed products beyond regulatory boundaries, impacting patient perceptions and adoption of adipose-derived stem cell therapies. Compliance with regulations is critical to ensure patient safety.

Infrastructure requirements, such as clean room facilities, specialized equipment, technical capabilities, and adherence to cGMP practices, limit SVF implementation to major hospitals in urban areas. Obtaining reimbursement for these procedures remains challenging, reducing market penetration.

Country-wise Insights

United States: Extensive Clinical Trials Fuel Demand

The U.S. market is booming due to a massive pipeline of SVF-derived cell therapies and extensive clinical trials assessing their efficacy for various purposes. The increasing number of clinical trials drives demand for SVF products, including proprietary SVF isolation devices and consumables.

India: Rise in Research and Development Activities

India is emerging as a lucrative market due to increased research and development activities focused on innovative SVF technologies. The expansion of private hospitals in rural areas contributes to market growth, making the Asian region attractive.

Germany: Musculoskeletal Disorders Drive Demand

Germany's growing aging population and rising awareness of stem cell therapy, particularly in musculoskeletal disorders like osteoarthritis, position the country as a prominent market for SVF treatments. Legal constraints on stem-cell research and therapy are expected to relax, further boosting market growth.

Competitive Landscape

Key market players emphasize product launches, strategic alliances, mergers, acquisitions, and facility expansions to enhance their market presence.

Key Companies in the Stromal Vascular Fraction (SVF) Market:

  • Cytori Therapeutics Inc.
  • IntelliCell BioSciences Inc.
  • Cellular Biomedicines Group, Inc.
  • GE Healthcare (Biosafe Group SA)
  • Lifecell Corporation (Allergen PLC)
  • Tissue Genesis Inc.
  • InGeneron, Inc.
  • Human med AG
  • MEDICAN CO., LTD
  • Hairline International
  • Genesis Biosystems, Inc.
  • iXCells Biotechnologies USA, LLC
  • Kyocera Corporation
  • Medikan International Inc.

Key Segments Covered in Manufacturing of Industry Research

Product:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products
  • Enzymatic Isolation Products
  • Non-enzymatic Isolation Products
  • Automated POC Devices

Application:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

End User:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Stromal Vascular Fraction Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 3.1. Global Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. SVF Aspiration Products
      • 3.1.1.2. SVF Transfer Products
      • 3.1.1.3. SVF Isolation Products
        • 3.1.1.3.1. Enzymatic Isolation Products
        • 3.1.1.3.2. Non-enzymatic Isolation Products
        • 3.1.1.3.3. Automated POC Devices
  • 3.2. Global Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cosmetic Applications
      • 3.2.1.2. Orthopedic Applications
      • 3.2.1.3. Soft Tissue Applications
      • 3.2.1.4. Others
  • 3.3. Global Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialty Clinics
      • 3.3.1.3. Stem Cell Banks/Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Stromal Vascular Fraction Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 4.1. North America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. SVF Aspiration Products
      • 4.1.1.2. SVF Transfer Products
      • 4.1.1.3. SVF Isolation Products
        • 4.1.1.3.1. Enzymatic Isolation Products
        • 4.1.1.3.2. Non-enzymatic Isolation Products
        • 4.1.1.3.3. Automated POC Devices
  • 4.2. North America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cosmetic Applications
      • 4.2.1.2. Orthopedic Applications
      • 4.2.1.3. Soft Tissue Applications
      • 4.2.1.4. Others
  • 4.3. North America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialty Clinics
      • 4.3.1.3. Stem Cell Banks/Laboratories
      • 4.3.1.4. Others
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 5.1. Europe Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. SVF Aspiration Products
      • 5.1.1.2. SVF Transfer Products
      • 5.1.1.3. SVF Isolation Products
        • 5.1.1.3.1. Enzymatic Isolation Products
        • 5.1.1.3.2. Non-enzymatic Isolation Products
        • 5.1.1.3.3. Automated POC Devices
  • 5.2. Europe Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cosmetic Applications
      • 5.2.1.2. Orthopedic Applications
      • 5.2.1.3. Soft Tissue Applications
      • 5.2.1.4. Others
  • 5.3. Europe Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialty Clinics
      • 5.3.1.3. Stem Cell Banks/Laboratories
      • 5.3.1.4. Others
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. SVF Aspiration Products
      • 6.1.1.2. SVF Transfer Products
      • 6.1.1.3. SVF Isolation Products
        • 6.1.1.3.1. Enzymatic Isolation Products
        • 6.1.1.3.2. Non-enzymatic Isolation Products
        • 6.1.1.3.3. Automated POC Devices
  • 6.2. Asia Pacific Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cosmetic Applications
      • 6.2.1.2. Orthopedic Applications
      • 6.2.1.3. Soft Tissue Applications
      • 6.2.1.4. Others
  • 6.3. Asia Pacific Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialty Clinics
      • 6.3.1.3. Stem Cell Banks/Laboratories
      • 6.3.1.4. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 7.1. Latin America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. SVF Aspiration Products
      • 7.1.1.2. SVF Transfer Products
      • 7.1.1.3. SVF Isolation Products
        • 7.1.1.3.1. Enzymatic Isolation Products
        • 7.1.1.3.2. Non-enzymatic Isolation Products
        • 7.1.1.3.3. Automated POC Devices
  • 7.2. Latin America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Cosmetic Applications
      • 7.2.1.2. Orthopedic Applications
      • 7.2.1.3. Soft Tissue Applications
      • 7.2.1.4. Others
  • 7.3. Latin America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialty Clinics
      • 7.3.1.3. Stem Cell Banks/Laboratories
      • 7.3.1.4. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. SVF Aspiration Products
      • 8.1.1.2. SVF Transfer Products
      • 8.1.1.3. SVF Isolation Products
        • 8.1.1.3.1. Enzymatic Isolation Products
        • 8.1.1.3.2. Non-enzymatic Isolation Products
        • 8.1.1.3.3. Automated POC Devices
  • 8.2. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cosmetic Applications
      • 8.2.1.2. Orthopedic Applications
      • 8.2.1.3. Soft Tissue Applications
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialty Clinics
      • 8.3.1.3. Stem Cell Banks/Laboratories
      • 8.3.1.4. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Segment 3 vs by Application Heat map
  • 9.2. Manufacturer vs by Application Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Cytori Therapeutics Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. IntelliCell BioSciences Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cellular Biomedicines Group, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. GE Healthcare (Biosafe Group SA)
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Lifecell Corporation (Allergen PLC)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Tissue Genesis Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. InGeneron, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Human med AG
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. MEDICAN CO., LTD
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Hairline International
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Genesis Biosystems, Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. iXCells Biotechnologies USA, LLC
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Kyocera Corporation
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Medikan International Inc
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations